This inventor holds 1 USPTO granted patent. Top assignee: Stolle Milk Biologics, Inc.. Active years: 2000.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2000
Title: Yasunobu Yoshikai: Innovator in Immunological Solutions
Introduction
Yasunobu Yoshikai is a notable inventor based in Higashi-ku, Japan, known for his significant contributions to the field of immunology. With a keen focus on enhancing immune functions, his work promises to improve health outcomes for aging and immunocompromised individuals.
Latest Patents
Yoshikai holds a patent for his invention regarding the "Use of hyperimmune milk to prevent suppression of T-lymphocyte production." This innovative method utilizes hyperimmune milk derived from milk-producing animals that have been hyperimmunized with bacterial antigens, including those from intestinal bacteria. His invention offers a novel approach to maintaining immunological health by effectively preventing the decline of immune functions typically observed in aging or immunocompromised animals.
Career Highlights
Yasunobu Yoshikai is associated with Stolle Milk Biologics, Inc., where he applies his expertise to develop and implement innovative solutions in the field of immunology. His pioneering work underlines the importance of nutritional support in bolstering immune responses and has implications for improving the overall health and longevity of vulnerable populations.
Collaborations
Throughout his career, Yoshikai has collaborated with esteemed colleagues, including Lee R Beck and Atsunori Ishida. These partnerships have helped foster an environment of innovation and research that enhances the effectiveness of the solutions they develop together.
Conclusion
Yasunobu Yoshikai's contributions to immunological research through his patented invention of hyperimmune milk exemplify how targeted innovations can tackle pressing health issues. His work continues to inspire future advancements in supporting immune functions and could significantly impact the health and well-being of aging and immunocompromised individuals.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile